hemophagocytic lymphohistiocytosis
Showing 1 - 25 of 32
Segmental Resection Combined With DEP Regimen for EBV-HLH
Not yet recruiting
- Hemophagocytic Lymphohistiocytosis
- +2 more
- Segmental bowel resection combined with the DEP regimen
-
Beijing, Beijing, ChinaZhao Wang
Nov 9, 2023
Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)
Not yet recruiting
- Refractory
- +2 more
- GTP regimen
- (no location specified)
Sep 8, 2023
PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)
Not yet recruiting
- PD-1 Antibody
- +3 more
- L-DEP and PD-1 antibody
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 8, 2023
Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)
Recruiting
- Hemophagocytic Lymphohistiocytosis
- Ruxolitinib
- +2 more
-
Phoenix, Arizona
- +9 more
Jan 9, 2023
Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,
Completed
- Hemophagocytic Lymphohistiocytosis
- +5 more
- Hematopoietic Stem Cell Transplant
-
Birmingham, Alabama
- +21 more
Dec 6, 2022
Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)
Recruiting
- Hemophagocytic Lymphohistiocytosis
- Venetoclax
- +2 more
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Sep 15, 2022
Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- iCaspase9-transduced T cells
- AP1903
-
Houston, Texas
- +1 more
Jul 22, 2022
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant
Recruiting
- Immune Deficiency Disorders
- +13 more
- Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
-
Saint Louis, MissouriWashington University
Apr 25, 2022
Hemophagocytic Lymphohistiocytosis Trial in Beijing (L-DEP and PD-1 antibody)
Not yet recruiting
- Hemophagocytic Lymphohistiocytosis
- L-DEP and PD-1 antibody
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Apr 19, 2022
Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)
Withdrawn
- Hemophagocytic Lymphohistiocytosis
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 11, 2022
Hemophagocytic Lymphohistiocytosis Trial in Beijing (DEP combine with PD-1 antibody)
Recruiting
- Hemophagocytic Lymphohistiocytosis
- DEP combine with PD-1 antibody
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Feb 13, 2022
Chidamide, Hemophagocytic Lymphohistiocytosis Trial in Beijing (Chidamide combines with VP-16 and methylprednisolone)
Recruiting
- Chidamide
- Hemophagocytic Lymphohistiocytosis
- Chidamide combines with VP-16 and methylprednisolone
-
Beijing, Beijing, ChinaBeijing Friendship Hospital
Nov 29, 2021
Adult Hemophagocytic Lymphohistiocytosis in Critically Ill
Recruiting
- Hemophagocytic Lymphohistiocytosis
-
Berlin, GermanyDepartment of Anesthesiology and Operative Intensive Care Medici
Jul 13, 2021
Hemophagocytic Lymphohistiocytosis Trial in Canada, United States (ATG, rabbit, Etoposide, Methotrexate)
Completed
- Hemophagocytic Lymphohistiocytosis
- ATG, rabbit
- +4 more
-
Phoenix, Arizona
- +14 more
Sep 21, 2020
Interferon Gamma and Other Inflammatory Mediators in
Completed
- Hemophagocytic Lymphohistiocytosis
- Blood Draws
- Data Collection
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 16, 2020
Hurler Syndrome, Fanconi Anemia, Glanzmann Thrombasthenia Trial in Atlanta (Abatacept)
Completed
- Hurler Syndrome
- +14 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Dec 20, 2019
Hemophagocytic Lymphohistiocytosis Trial in Beijing (low dose ruxolitinib, high dose ruxolitinib)
Unknown status
- Hemophagocytic Lymphohistiocytosis
- low dose ruxolitinib
- high dose ruxolitinib
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Oct 27, 2019
Hemophagocytic Lymphohistiocytosis Trial in Beijing (Pegylated liposomal doxorubicin, Etoposide, Methylprednisolone)
Unknown status
- Hemophagocytic Lymphohistiocytosis
- Pegylated liposomal doxorubicin
- +2 more
-
Beijing, ChinaBeijing Friendship Hospital
Sep 4, 2019
Ferritin in Critically Ill Special Focus on Underlying
Completed
- Hemophagocytic Lymphohistiocytosis
- (no location specified)
Aug 19, 2019
Hemophagocytic Lymphohistiocytosis Trial in Beijing (Ruxolitinib, Dexamethasone)
Unknown status
- Hemophagocytic Lymphohistiocytosis
-
Beijing, Chaoyang District, China
- +1 more
Jan 5, 2019
Hemophagocytic Lymphohistiocytosis Trial in Beijing (Etoposide, Dexamethasone, IVIG)
Unknown status
- Hemophagocytic Lymphohistiocytosis
- Etoposide
- +2 more
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Nov 13, 2018
Hemophagocytic Lymphohistiocytosis Trial in Seoul (IST and/or alloHCT)
Terminated
- Hemophagocytic Lymphohistiocytosis
- IST and/or alloHCT
-
Seoul, Korea, Republic ofAsan Medical center, University of Ulsan College of Medicine
Jul 19, 2018
Hemophagocytic Lymphohistiocytosis Trial in Stockholm (Dexamethasone, Etoposide, Cyclosporin)
Completed
- Hemophagocytic Lymphohistiocytosis
- Dexamethasone
- +4 more
-
Stockholm, SwedenChildhood Cancer Research Unit, Karolinska Hospital
Jul 2, 2018
Hemophagocytic Lymphohistiocytosis Trial in Beijing (DEP-Ru)
Unknown status
- Hemophagocytic Lymphohistiocytosis
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
May 26, 2018